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ABSTRACT 
 Huntington’s disease (HD) is caused by expansion of a polyglutamine (polyQ) repeat in 
the huntingtin protein. A structural basis for the apparent transition between normal and 
disease-causing expanded polyQ repeats of huntingtin is unknown. The ‘linear lattice’ model 
proposed random-coil structures for both normal and expanded polyQ in the preaggregation 
state. Consistent with this model, the affinity and stoichiometry of the anti-polyQ antibody MW1 
increased with the number of glutamines. An opposing ‘structural toxic threshold’ model 
proposed a conformational change above the pathogenic polyQ threshold resulting in a specific 
toxic conformation for expanded polyQ. Support for this model was provided by the anti-polyQ 
antibody 3B5H10, which was reported to specifically recognize a distinct pathologic 
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conformation of soluble expanded polyQ. To distinguish between these models, we directly 
compared binding of MW1 and 3B5H10 to normal and expanded polyQ repeats within huntingtin 
exon 1 fusion proteins. We found similar binding characteristics for both antibodies. First, both 
antibodies bound to normal, as well as expanded, polyQ in huntingtin exon 1 fusion proteins. 
Second, an expanded polyQ tract contained multiple epitopes for antigen-binding fragments 
(Fabs) of both antibodies, demonstrating that 3B5H10 does not recognize a single epitope 
specific to expanded polyQ. Finally, small angle X-ray scattering and dynamic light scattering 
revealed similar binding modes for MW1 and 3B5H10 Fab-huntingtin exon 1 complexes. 
Together, these results support the linear lattice model for polyQ binding proteins, suggesting 
that the hypothesized pathologic conformation of soluble expanded polyQ is not a valid target 
for drug design. 
 
KEYWORDS 
Equilibrium gel filtration; Huntington’s disease; linear lattice; polyglutamine; small angle 
X-ray scattering 
 
ABBREVIATIONS 
 AUC, analytical ultracentrifugation; CDR, complementarity determining region; Fab, 
antigen-binding fragment; HC, heavy chain; HD, Huntington’s disease; LC, light chain; MALS, 
multiangle light scattering; polyQ, polyglutamine; Rg, radius of gyration; Rh, hydrodynamic 
radius; SAXS, small angle X-ray scattering; SEC, size-exclusion chromatography; SPR, surface 
plasmon resonance; SSRL, Stanford Synchrotron Radiation Lightsource; TRX, thioredoxin; VH, 
heavy chain variable domain; VL, light chain variable domain 
 
INTRODUCTION 
Huntington’s disease (HD) is a fatal neurodegenerative disorder characterized clinically 
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by psychiatric symptoms, cognitive decline, and uncontrolled movements [1]. HD is caused by 
expansion of a CAG repeat within exon 1 of HTT (previously HD) that encodes an expanded 
polyglutamine (polyQ) tract in the N-terminal portion of the huntingtin protein. A pathologic 
threshold exists for HD, in which HD is fully penetrant in patients with 42 or more glutamines in 
the huntingtin protein, but no disease is found in individuals with 36 or fewer glutamines, while 
huntingtin with 37 to 41 glutamines exhibits reduced HD penetrance [2]. Although a structural 
basis for an apparent normal-disease threshold is unknown, several hypotheses exist for the 
conformation of monomeric, soluble polyQ in normal and expanded huntingtin protein. 
The ‘linear lattice’ hypothesis proposed that polyQ retains a random-coil structure for 
both normal and expanded polyQ in the preaggregation state. In this model, the increase in 
number of binding epitopes in expanded polyQ compared with normal polyQ results in avidity 
effects that cause higher apparent affinities for bivalent proteins such as antibodies [3]. This 
could induce altered binding interactions with other cellular proteins or other polyQ repeats, 
leading to neuronal toxicity. Consistent with this model, the affinity of the anti-polyQ antibody 
MW1 to huntingtin amino terminal protein encoded by exon 1 (hereafter called huntingtin exon 1 
protein) increased in a polyQ-length dependent manner, and binding of multiple antigen-binding 
fragments (Fabs) of MW1 to expanded polyQ tracts was observed. In addition, huntingtin exon 1 
protein with 16 – 46 glutamines exhibited a random coil conformation in solution, and no 
evidence was found for a global conformation change above 37 glutamines [3, 4]. Surface 
plasmon resonance (SPR) and analytical ultracentrifugation (AUC) studies also demonstrated 
that multiple MW1 Fabs bound to expanded polyQ tracts [3]. The X-ray crystal structure of a 
GQ10G peptide bound to the variable regions of MW1 revealed that a short polyQ tract adopted 
an extended structure in a diagonal binding groove across the antigen-binding site of MW1 [4]. 
Additional binding studies using the anti-polyQ antibody 1C2 [5] showed that 1C2 also exhibited 
preferential binding to expanded polyQ due to avidity effects, and this preferential binding was 
not due to a mutant huntingtin-specific toxic structure recognized by 1C2 [6]. 
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In contrast, the ‘structural toxic threshold’ model proposed that a conformational 
transition occurs in polyQ repeats that are longer than the pathological threshold, which results 
in a specific toxic conformation for monomeric expanded polyQ that could potentially be 
recognized by antibodies [7]. According to this model, the postulated pathologic conformation 
could be directly toxic or it could alter interactions between mutant huntingtin and its binding 
partners; in either case, the pathologic conformation could be targeted for drug design. Support 
for this model was provided by studies of the anti-polyQ antibody 3B5H10, which was reported 
to recognize a single epitope representing a distinct pathologic conformation of soluble 
expanded polyQ [8, 9]. In these studies, 3B5H10 IgG preferentially bound to expanded polyQ, 
and a two-stranded β-hairpin conformation of polyQ was modeled into the predicted polyQ-
binding groove of the 3B5H10 Fab structure [9]. Support for this model was provided by a gel 
filtration assay of 3B5H10 Fab binding to a Q39-containing huntingtin exon 1 fusion (HD-39Q) 
protein, which was interpreted to demonstrate a binding stoichiometry of 1:1 3B5H10 Fab:HD-
39Q [8]. These results were suggested to indicate that 3B5H10 binds to a single structured 
polyQ epitope only present in expanded polyQ, as per the structural toxic threshold hypothesis. 
Modeling of small-angle X-ray scattering (SAXS) data was interpreted as showing that 3B5H10 
Fab bound to HD-39Q in a 2:2 3B5H10 Fab:HD-39Q complex in which each 3B5H10 Fab 
recognized one subunit of an HD-39Q dimer through binding to a two-stranded β-hairpin 
conformation of polyQ [9]. Contradictory evidence was provided by a recent report 
demonstrating that pull-down assays and surface plasmon resonance (SPR) studies showed 
that 3B5H10 IgG, like MW1 and 1C2 IgGs, could bind to short polyQ tracts, as expected given 
the high sequence and structural similarities between the three antibodies [6]. 
 Here we compared the recognition properties of the anti-polyQ monoclonal antibodies 
MW1 and 3B5H10 by studying their interactions with a polyQ-containing fragment of huntingtin. 
Using expressed and purified huntingtin exon 1-thioredoxin (TRX) fusion proteins containing 16 
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to 46 glutamines (HD-16Q, HD-25Q, HD-39Q, HD-46Q) (Fig. 1a), we directly compared the 
interactions between soluble huntingtin and these anti-polyQ antibodies using biochemical and 
biophysical analysis techniques. We found that both MW1 and 3B5H10 antibodies exhibited 
similar binding properties, with neither providing evidence for a toxic conformation of expanded 
polyQ. These results argue against strategies designed to target a novel toxic conformation of 
soluble mutant huntingtin exon 1 protein in the preaggregation state. 
 
RESULTS 
Both MW1 and 3B5H10 antibodies bind to normal and expanded polyQ within huntingtin 
exon 1 proteins 
Western blots were used to evaluate the binding of 3B5H10 and MW1 IgGs to equimolar 
amounts of huntingtin exon 1-TRX fusion proteins and to the TRX tag alone (Fig. 1b). If 3B5H10 
recognizes a toxic conformation present only in expanded polyQ, then unlike MW1, it should not 
bind to short polyQ repeats. In contrast with some previous results [9], but consistent with other 
results [10, 11], we found that both MW1 and 3B5H10 IgGs bound in a similar manner to 
huntingtin exon 1 fusion proteins, each capable of binding to huntingtin exon 1 proteins 
containing both normal and expanded polyQ repeats. Both IgGs bound to huntingtin exon 1 
proteins in a polyQ-dependent manner, with a progressively more intense signal with increased 
polyQ length. Based on these results, and previous western blots demonstrating the ability of 
3B5H10 to bind to GST-polyQ with both short and long polyQ repeats [6], we conclude that both 
antibodies recognize a similar polyQ epitope that is present in both normal and expanded 
huntingtin exon 1 proteins. 
In order to determine how it is possible to obtain results appearing to indicate that 
3B5H10 binds only to expanded polyQ, we examined binding of 3B5H10 and MW1 as a function 
of concentration to huntingtin exon 1 proteins with different polyQ repeat lengths. Dot blots of 
serial dilutions of huntingtin exon 1 proteins demonstrated that both 3B5H10 and MW1 IgGs 
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bound to huntingtin exon 1 proteins in a length- and concentration-dependent manner (Fig. 1c). 
At higher concentrations of huntingtin exon 1 protein, both IgGs recognized huntingtin exon 1 
constructs with polyQ tracts ranging from Q16 to Q46. However, at lower concentrations of 
huntingtin exon 1 protein, a more intense signal was observed for the huntingtin exon 1 
construct with the longest polyQ repeat (HD-46Q) compared to the construct with the shortest 
polyQ repeat (HD-16Q) (Fig. S1b,c). Due to the length- and concentration-dependent binding, 
conditions can be found in which MW1 or 3B5H10 IgG appeared to only bind expanded polyQ, 
thus explaining previously-reported results that 3B5H10 only recognizes huntingtin with 
expanded polyQ [9]. However, for both antibodies, the binding dependence on polyQ length was 
progressive, without a distinct threshold at polyQ lengths >37Q. Thus, avidity effects resulted in 
bivalent IgG versions of 3B5H10 and MW1 showing preferential binding to expanded polyQ, as 
predicted by the linear lattice model for antibody interactions with polyQ repeats [3, 12]. 
 
Huntingtin exon 1 proteins are monomeric in solution 
 During purification of huntingtin exon 1 fusion proteins, we observed anomalous 
migration by gel filtration chromatography such that huntingtin exon 1 fusion proteins appeared 
to migrate as higher molecular weight proteins (e.g., dimers) when compared with molecular 
weight standards of globular proteins. To determine the oligomeric state of the huntingtin exon 1 
fusion proteins, we used a combination of size-exclusion chromatography (SEC) with in-line 
multiangle light scattering (SEC-MALS), a technique that can be used to determine the absolute 
molecular mass of a protein or complex independent of shape and model [13]. To evaluate the 
methodology, we first analyzed 3B5H10 Fab alone, which migrated as a single monodisperse 
peak whose derived molecular mass closely matched the mass calculated from the amino acid 
sequence (Fig. 2; Table 1). HD-16Q and HD-39Q fusion proteins also migrated as 
monodisperse peaks, and their calculated molecular masses corresponded to monomers in 
each case (Table 1). Thus the anomalous migration of each huntingtin exon 1 protein in 
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positions expected for a dimeric version of a globular protein of the same molecular mass 
results from slower migration due to an elongated structure rather than from dimerization. In 
particular, no evidence was found for dimer formation for HD-39Q as predicted in a previous 
study involving the modeling of small-angle X-ray scattering (SAXS) data [9]. 
 
Non-equilibrium gel filtration chromatography analyses yield inconsistent apparent 
binding stoichiometries 
We next replicated published non-equilibrium gel filtration chromatography experiments 
that were conducted to determine the stoichiometry of binding between 3B5H10 Fab and 
huntingtin exon 1 protein with an expanded polyQ repeat using the same proteins: 3B5H10 Fab 
and HD-39Q [8]. By varying the ratio of 3B5H10 Fab to HD-39Q, we determined the ratio where 
the least amount of excess Fab or excess HD-39Q was detected, the method previously used to 
report a 1:1 3B5H10:HD-39Q binding stoichiometry [8]. Similar to the published results, we 
found that unbound 3B5H10 Fab was present at ratios greater than 1:1 3B5H10 Fab:HD-39Q, 
unbound HD-39Q was present at ratios less than 1:1, and that the ratio where the least amount 
excess of Fab or excess HD-39Q could be detected was 1:1 (Fig. 3a). As a control, we repeated 
the non-equilibrium gel filtration stoichiometry experiment to evaluate the binding behavior of 
MW1 Fab and HD-39Q (Fig. 3b), which was previously shown to form a complex with a greater 
than 1:1 stoichiometry [3]. Under non-equilibrium conditions, the stoichiometry of MW1 Fab:HD-
39Q appeared to be less than 1:1. Thus it appeared that non-equilibrium gel filtration could not 
be reliably used to derive an accurate binding stoichiometry for an anti-polyQ Fab binding to 
huntingtin exon 1 fusion proteins with expanded polyQ. 
However, we noted that with increasing molar ratios of 3B5H10 Fab:HD-39Q, the 
complex peak eluted earlier on the gel filtration column, suggesting that a complex larger than 
1:1 was forming at the same time as 3B5H10 Fab was dissociating from HD-39Q. Due to the 
anomalous migration of HD-39Q compared with globular proteins using gel filtration 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
8 
chromatography (see above), the molecular mass of the 3B5H10 Fab:HD-39Q complex peak 
could not accurately be estimated based on gel filtration migration. Using SEC-MALS, we found 
that the complex of 3B5H10 Fab and HD-39Q was polydisperse, and the molecular mass of the 
peak fraction corresponded to a complex composed of greater than a 1:1, but less than a 2:1, 
ratio of 3B5H10 Fab:HD-39Q (Table 1), demonstrating that dissociation of the complex occurred 
during the experiment. In contrast, the complex of 3B5H10 Fab and HD-16Q migrated as a 
monodisperse peak, and the calculated molecular mass for a 1:1 3B5H10 Fab:HD-16Q 
stoichiometric ratio was in close agreement with the molecular mass obtained by SEC-MALS 
(Table 1). 
 Taken together, the results for these experiments suggested that binding stoichiometries 
for MW1 and 3B5H10 Fabs binding to huntingtin exon 1 proteins as determined by non-
equilibrium gel filtration are incorrect. This is likely because protein complexes that dissociate 
during this procedure are unable to rebind due to separation by the gel filtration column. 
Therefore depending on the binding kinetics and the amount of separation between anti-polyQ 
Fabs and huntingtin exon 1 proteins on the gel filtration column, the binding stoichiometries 
determined by non-equilibrium gel filtration techniques may be artificially low, as has been found 
in other protein-protein interaction systems evaluated by this technique [14, 15]. 
 
Expanded polyQ tracts within huntingtin exon 1 proteins contain multiple epitopes for 
the antigen-binding fragments (Fabs) of MW1 and 3B5H10 
To determine an accurate stoichiometry of binding between HD-39Q and the Fabs of 
3B5H10 and MW1, we used equilibrium gel filtration [16]. In this technique, a chromatography 
column is run with an equilibration buffer containing one of the binding partners (e.g., protein A). 
Different ratios of the binding partners (e.g., protein A and protein B) are then injected onto the 
column. When the amount of additional protein A injected is less than that required for formation 
of a complex, a trough will form at the position that protein A migrates. If the amount of 
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additional protein A injected is in excess for complex formation, a peak is observed at the 
position that protein A migrates. When the amount of additional protein A injected is at the 
amount required for complex formation, a flat baseline is observed at the position that protein A 
migrates. However, unless the protein concentration in the equilibration buffer is much greater 
than the affinity of the protein-protein complex, the ratio of protein A to protein B at which a flat 
baseline is observed will not be an integer, in which case the correct stoichiometry can be 
obtained by rounding up to the next integer [14] or by Scatchard analysis [15]. Previous 
measurements demonstrated a higher polyQ binding affinity for 3B5H10 Fab than for MW1 Fab: 
KD = 1.0 µM for 3B5H10 Fab binding to a Q22 or Q41 peptide [6] versus KD = 2.2 µM for MW1 
Fab binding to HD-39Q [3]. Therefore we used higher concentrations of MW1 Fab (1-10 µM) 
than 3B5H10 Fab (0.5-5 µM) in these experiments. 
Complexes containing different ratios of Fab and HD-39Q were incubated together and 
injected onto a gel filtration column equilibrated with the appropriate Fab. A series of 
experiments with different concentrations of 3B5H10 Fab in the equilibration buffer were 
performed. For example, for 5 µM of 3B5H10 Fab in the equilibration buffer, the stoichiometry at 
which no peak or trough was observed was ~2.6:1 (Fig. 4a). Analysis with MW1 Fab yielded 
similar results, with the MW1 Fab:HD-39Q stoichiometry approaching 3:1 (Fig. 4b). Therefore 
for both antibodies, the stoichiometry of binding was determined as 3:1 Fab:HD-39Q. 
 
Dynamic light scattering (DLS) revealed similar sizes for complexes of MW1 and 3B5H10 
Fabs with huntingtin exon 1 proteins 
To further investigate complexes of anti-polyQ Fabs bound to huntingtin exon 1 proteins, 
we used dynamic light scattering (DLS) to compare hydrodynamic radii (Rh) of 3B5H10 and 
MW1 Fabs alone, HD-16Q and HD-39Q alone, and complexes of Fab and huntingtin exon 1 
protein. Fab complexes with HD-16Q were prepared at a 1:1 Fab:HD-16Q molar ratio, while 
complexes with HD-39Q were prepared at a 3:1 molar ratio. Concentrations of proteins and 
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complexes varied from 1-7 mg/mL, higher than the concentrations used for equilibrium gel 
filtration experiments. As expected, the Rh values derived for the 3B5H10 and MW1 Fabs, which 
are globular proteins of similar dimensions, were roughly the same, and both Rh values were 
smaller than the Rh values for HD-16Q and HD-39Q (Table 2), consistent with the proposed 
elongated structures of HD-16Q and HD-39Q [3] (Table 2). Notably, the Rh value for HD-16Q 
was smaller than for HD-39Q, inconsistent with the compact structure proposed for expanded 
polyQ [9]. When complexed with huntingtin exon 1 proteins, both Fabs exhibited qualitatively 
similar behavior: the Rh values were lower for the Fab complexes with HD-16Q than with HD-
39Q. Based on our gel filtration and SEC-MALS data (Fig. 2,4), the complexes being examined 
by DLS were likely to be 1:1 Fab:HD-16Q complexes and a mixture of 2:1 and 3:1 Fab:HD-39Q 
complexes for both Fabs. Consistent with our other results, the 3B5H10 and MW1 Fabs did not 
exhibit different properties when binding to huntingtin exon 1 proteins as would have been 
expected if 3B5H10, but not MW1, recognized a pathologic conformation of expanded polyQ. 
  
Small-angle X-ray scattering revealed similar predicted characteristics for complexes of 
MW1 and 3B5H10 Fabs with huntingtin exon 1 proteins 
 We next repeated published small-angle X-ray scattering (SAXS) studies for HD-39Q 
alone and complexed with 3B5H10 Fab [9], comparing results with SAXS data for analogous 
complexes with MW1 Fab and HD-16Q. We collected SAXS data for samples of 3B5H10 and 
MW1 Fabs alone, HD-16Q, HD-25Q, HD-39Q, and HD-46Q alone, and complexes of each Fab 
with HD-16Q and HD-39Q. With the exception of the HD-46Q alone sample, the scattering 
profiles for the Fabs, huntingtin exon 1 fusion proteins alone, and Fab:HD-16Q and Fab:HD-
39Q complexes showed ideal sample quality characteristics (Fig. S2). Guinier analysis [17] 
indicated minimal aggregation for both Fabs alone and Fabs complexed with HD-16Q and HD-
39Q and for all huntingtin exon 1 fusion proteins alone (Fig. S3). Radii of gyration (Rg) 
determined by SAXS were consistent with Rh values determined by DLS (Table 2). In particular, 
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for measurements of huntingtin exon 1 fusion proteins alone, we did not see substantially 
increased Rh or Rg values for HD-39Q compared with HD-16Q, consistent with computational 
modeling of polyQ in aqueous solution suggesting that radii of polyQ tracts of increasing lengths 
are similar [18], but inconsistent with the structural toxic threshold model predicting a 
conformational transition for expanded polyQ tracts [9]. The predicted molecular weights of the 
complexes of 3B5H10 or MW1 Fab bound to HD-16Q in a 1:1 complex were similar to the 
molecular weights calculated based on the extrapolated scattering intensity at zero angle [19]. 
However, 3B5H10 Fab or MW1 Fab bound to HD-39Q formed complexes with observed 
molecular weights larger than a 1:1 complex. Based on molecular weight alone, these 
complexes could be 2:1, 3:1, or 2:2 Fab:HD-39Q complexes. A 2:2 3B5H10 Fab:HD-39Q 
stoichiometry was postulated to account for previous SAXS data [9]. However, our SEC-MALS 
and equilibrium gel filtration data demonstrated that 3B5H10 Fab does not bind to HD-39Q in a 
2:2 ratio (Fig. 2). Therefore, we interpret our SAXS data for both 3B5H10 and MW1 Fab binding 
to HD-39Q as evidence for mixtures of 2:1 and 3:1 Fab:HD-39Q complexes. 
Kratky analysis was used to evaluate the relative degree of folding of each sample [20]. 
The Kratky plots for MW1 and 3B5H10 Fabs alone yielded bell-shaped peaks consistent with 
globular proteins [21, 22] (Fig. 5a). By contrast, the Kratky plots for HD-16Q and HD-39Q were 
broader, with less degrease at higher scattering angles, consistent with flexible or unfolded 
proteins [21, 22] (Fig. 5b). Thus we found no evidence for a conformational change occurring for 
HD-39Q relative to HD-16Q. Similarly, we found no systematic differences for 3B5H10 versus 
MW1 Fab complexes with either HD-16Q or HD-39Q (Fig. 5c,d). These results are consistent 
with both Fabs exhibiting similar recognition properties for polyQ tracts. 
 Three-dimensional structures can be modeled into SAXS profiles; however, modeling is 
limited by the one-dimensional nature of SAXS data, and more than one 3-D shape can produce 
the same one-dimensional scattering profile [23]. We did not attempt to fit atomistic models into 
the SAXS data as done in a previous study [9] because (i) the complete 3-D structure of 
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huntingtin exon 1 protein is unknown, (ii) the polyQ tract within huntingtin exon 1 fusion proteins 
adopts flexible random coil structures in solution [3], and (iii) the arrangements between polyQ 
tracts, the remainder of huntingtin exon 1, the TRX fusion partner, and the His purification tag 
cannot be predicted. Nor did we assume that the huntingtin exon 1 fusion proteins were dimeric, 
as also done for interpretation of SAXS data involving HD-39Q bound to 3B5H10 Fab [9], 
because our SEC-MALS data demonstrated that HD-39Q is monomeric in solution (Fig. 2). 
Instead, we used minimal assumptions to generate ab initio models that predicted molecular 
envelopes from the SAXS data for each of the well-behaved samples. We did not find notable 
differences between 3B5H10:HD-39Q and MW1:HD-39Q complexes based on Rg, Dmax, or 
shape or volume of calculated envelopes (Fig. 6, Table 2), as would be predicted by the toxic 
conformation model suggesting that 3B5H10, but not MW1, recognizes a compact conformation 
of expanded polyQ [9]. Instead, in agreement with experiments described above and in previous 
reports [3, 4, 6, 12], the SAXS results were consistent with recognition of multiple epitopes 
within a linear lattice of expanded polyQ by both Fabs. 
 
DISCUSSION 
 The structure of huntingtin exon 1 protein in the preaggregation state, particularly the 
conformation of the expanded polyQ repeat, is hypothesized to be critical in understanding the 
pathogenesis of HD. However, the structure of the basic components of huntingtin exon 1 
remains controversial. An X-ray crystal structure of a Q17 huntingtin N-terminal region fused to 
MBP showed that a short polyQ region could adopt either α-helical, loop, or random coil 
conformations [24]. The structure of a Q10 peptide bound to the anti-polyQ antibody MW1 
revealed an extended structure [4]. Other recent work suggested that the polyQ repeat acts as a 
flexible hinge that exhibits reduced flexibility at extended polyQ lengths [25]. In the present 
study, we show that the binding properties of the anti-polyQ antibodies MW1 and 3B5H10 
support the ‘linear lattice’ model for the structure of soluble polyQ in the context of a huntingtin 
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exon 1 fusion protein. This model postulates that both normal and expanded polyQ tracts in the 
preaggregation state are random-coil structures, with expanded polyQ repeats containing more 
epitopes recognized by antibodies or other binding proteins than normal polyQ tracts [3]. 
Several lines of evidence, reported here and in previous publications [6, 11], have shown that 
3B5H10 and MW1 IgGs can bind to a normal polyQ repeat, demonstrating that neither antibody 
preferentially recognizes a novel structure formed by expanded polyQ, but instead both 
recognize a short stretch of polyQ. This conclusion is in contrast to other studies suggesting that 
3B5H10 bound preferentially to expanded polyQ repeats of mutant huntingtin according to a 
‘structural toxic threshold’ model, in which a conformational transition occurs in the polyQ repeat 
of huntingtin exon 1 protein at the pathologic threshold (>37Q) [9]. Instead our results agree 
with the conclusions of a recent study comparing the binding of anti-polyQ antibodies 1C2 and 
3B5H10 to polyQ repeats [6].  
 To evaluate whether an expanded polyQ tract contains one epitope for anti-polyQ Fabs 
as predicted by the structural toxic threshold model, or multiple epitopes for the Fabs as 
predicted by the linear lattice model, we evaluated complexes using equilibrium gel filtration 
chromatography. Our results demonstrated that the stoichiometry of both 3B5H10 Fab:HD-39Q 
and MW1 Fab:HD-39Q complexes was ~3:1 Fab:HD-39Q for both Fabs, thus neither Fab 
preferentially recognizes a novel structure formed by expanded polyQ. Consistent with this 
result, we confirmed that both 3B5H10 and MW1 IgGs recognized unexpanded polyQ, in direct 
contradiction to the structural toxic threshold model. We also used SAXS and DLS to further 
study the conformation of normal and expanded forms of huntingtin exon 1 protein, alone and in 
complex with MW1 or 3B5H10 Fab. This allowed us to determine the globularity of the protein 
complexes and their approximate oligomeric states, which revealed striking similarities between 
MW1 and 3B5H10 Fabs, both when unliganded and when bound to HD-16Q or HD-39Q. Thus a 
combination of equilibrium gel filtration chromatography, DLS, and SAXS data are consistent 
with a linear lattice mode of recognition of unstructured polyQ for both 3B5H10 and MW1 
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antibodies. Sharing the same general ligand-binding properties is consistent with the high 
degree of sequence and structural similarity relating 3B5H10 and MW1 [6]: the variable regions 
are related by 53% (VH domain) and 99% (VL domain) sequence identity and a root mean 
square deviation of 0.59 Å for superposition of VH-VL regions of the 3B5H10 (PDB code 3S96) 
and MW1 (PDB code 2GSG) crystal structures (calculated for all Cα atoms). In addition, the 
antigen-binding sites of both antibodies include an unusual diagonal groove [6] shown to 
accommodate a single extended stretch of polyQ in an MW1-polyQ co-crystal structure [4], and 
thus unlikely to bind to a two-stranded β-hairpin structure of polyQ, as modeled for the HD-39Q 
interaction with 3B5H10 Fab [9]. 
 Reduced penetrance is seen in patients with between 37 and 41 glutamine repeats in 
the huntingtin protein, which may be best explained by a quantitative change in a rate-limiting 
process in which the effects can be countered in some patients and not in others due to 
environmental or genetic modifiers. This reduced penetrance is consistent with a continuous 
linear lattice effect that is weak at lower polyQ repeat lengths and progressively stronger at 
larger repeat lengths. These results are relevant to potential therapeutic approaches to target 
soluble expanded polyQ in a lag period preceding aggregation. As we find no evidence for 
recognition of a specific conformation of expanded polyQ within huntingtin exon 1 proteins in 
either this study or previous studies [3, 4, 6, 12], we suggest that efforts to target expanded 
polyQ using monomeric binding partners are unlikely to be successful in discriminating polyQ 
stretches found in non-disease proteins such as transcription factors [26, 27] from expanded 
polyQ within mutant huntingtin exon 1. Instead, we suggest strategies in which reagents that 
recognize short stretches of polyQ are covalently linked to allow avidity effects to discriminate 
between short and expanded polyQ tracts. 
 
MATERIALS AND METHODS 
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Protein expression and purification 
Human huntingtin exon 1 encoded protein (comprising 91 amino acids when containing 
16 glutamine residues) including different sized polyQ segments (Q16, Q25, Q39, and Q46) 
coded for by CAG or CAA/CAG repeats was expressed as a fusion protein with thioredoxin 
(TRX). Exon 1 fusion proteins were purified as previously described [3] with the following 
modifications: autoinduction was used to culture cells to high densities [28], and sonication was 
used for cell lysis. Purified proteins were flash frozen and stored at -80°C in 50 mM Tris (pH 8.0) 
and 150 mM NaCl. 
MW1 IgG2b was purified from ascites fluid by protein A affinity chromatography (GE 
Healthcare). MW1 Fab was prepared by papain cleavage of MW1 IgG using a ratio of 1:25 
(papain:MW1 by weight) for 30 minutes at 37°C. Fabs were separated from the Fc fragment 
using protein A affinity chromatography (GE Healthcare) and then further purified by gel filtration 
chromatography (Superdex 200 10/300 GL). 
3B5H10 Fab was expressed and purified as previously described for other IgGs [29]. 
Briefly, the 3B5H10 light chain (LC) gene and a C-terminally 6x-His tagged heavy chain (HC) 
gene were subcloned separately into the pTT5 mammalian expression vector (NRC 
Biotechnology Research Institute), and 3B5H10 Fab was expressed by transient co-transfection 
of HEK293-6E (NRC Biotechnology Research Institute) cells and purified from supernatants 
using Ni2+-NTA affinity chromatography and gel filtration chromatography (Superdex 200 10/300 
or 16/60). 
Protein concentrations were determined using 280 nm extinction coefficients of 80,830 
M-1 cm-1 (3B5H10 Fab), 78,310 M-1 cm-1 (MW1 Fab), 14,180 M-1 cm-1 (TRX), 14,180 M-1 cm-1 
(HD-16Q), and 14,180 M-1 cm-1 (HD-39Q). Extinction coefficients were calculated based on 
amino acid sequence using ProtParam (http://web.expasy.org/protparam/protpar-ref.html).  
 
Western and dot blot analyses 
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Equimolar amounts of purified huntingtin exon 1 protein and TRX were loaded and 
separated on an Any kD Mini-PROTEAN gel (Bio-Rad Laboratories, Hercules, CA) at 175 V for 
40 minutes, followed by transfer to a nitrocellulose membrane at 100 V for 1 hour. After blocking 
for 1 hour in TBST with 3% BSA, membranes were incubated overnight at 4°C with 3B5H10 IgG 
(Sigma, St. Louis, MO), MW1 IgG (purified from ascites), or rabbit polyclonal N17 huntingtin IgG 
[30] at 1:75,000 or, 1:10,000, or 1:7,500 respectively. Membranes were washed with TBST and 
incubated with HRP-conjugated anti-mouse IgG (Jackson Immunoresearch Laboratories, West 
Grove, PA) or HRP-conjugated anti-rabbit IgG (Jackson Immunoresearch Laboratories) for 1 
hour at room temperature. Membranes were washed again, and antibody binding was detected 
using Amersham Enhanced Chemiluminescence (ECL) Prime Western Blotting Detection 
Reagent (GE Life Sciences, Uppsala, Sweden). Western blots were imaged using a ChemiDoc 
MP Imaging System (Bio-Rad Laboratories). Equimolar amounts of purified huntingtin exon 1 
protein and TRX were also analyzed by SDS-PAGE on an Any kD Mini-PROTEAN gel (Bio-Rad 
Laboratories) and stained with Coomassie. 
Equimolar amounts of huntingtin exon 1 fusion protein and TRX were serially diluted in 
50 mM Tris (pH 8.0), 150 mM NaCl and spotted onto nitrocellulose membranes. Membranes 
were washed with TBST and probed with 3B5H10, MW1, or mouse monoclonal anti-TRX 
(Genscript, Piscataway, NJ) IgGs overnight at 4°C. HRP-conjugated goat anti-mouse secondary 
antibody (Jackson Immunoresearch Laboratories) was used to quantitate antibody binding to 
proteins on the membrane, and antibody binding was detected using Amersham ECL Prime 
Western Blotting Detection Reagent (GE Life Sciences). Densitometry of blots was performed 
using Image Lab 5.2.1 Software (Bio-Rad Laboratories). Densities were expressed as a ratio 
relative to the density observed for HD-16Q (western blots) or 20 pmol HD-16Q (dot blots). 
 
SEC-MALS 
Purified proteins or protein complexes were characterized by SEC-MALS to determine 
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absolute molecular masses [13]. Proteins were concentrated to 1 mg/mL, passed through a 0.2 
µm filter (Millipore), and injected onto a Superdex 200 10/300 GL gel-filtration chromatography 
column equilibrated in a buffer containing 20 mM Tris (pH 8.0) and 100 mM NaCl. The 
chromatography system was connected with an 18-angle light-scattering detector (DAWN 
HELEOS II; Wyatt Technology), a dynamic light-scattering detector (DynaPro Nanostar; Wyatt 
Technology), and a refractive index detector (Optilab t-rEX; Wyatt Technology). Data were 
collected every second at a flow rate of 0.5 mL/min at 25°C. Data analysis was carried out using 
the program ASTRA 6, yielding the molar mass and distribution of mass (polydispersity) of the 
sample. 
 
Non-equilibrium gel filtration chromatography 
Non-equilibrium protein interaction experiments were carried out on a Superdex 200 PC 
3.2/30 gel-filtration column (GE Healthcare) equilibrated in a buffer containing 50 mM Tris (pH 
8.0) and 150 mM NaCl. A final concentration of 7 µM HD-39Q was used for all experiments, with 
3B5H10 and MW1 Fab concentrations varied to create Fab:HD-39Q complexes with final molar 
ratios of 0.25:1, 0.5:1, 1:1, 1.5:1, 2:1, and 3:1. 50 µL of each complex was injected and flowed 
through the column at 50 µL/min at room temperature. The absorbance of the eluent was 
monitored at 280 nm. 
 
Equilibrium gel filtration chromatography 
A Superdex 200 PC 3.2/30 (GE Healthcare) gel filtration column was equilibrated and 
run with equilibration buffer: 50 mM Tris (pH 8.0), 150 mM NaCl and a specific concentration of 
3B5H10 Fab (0.5 µM, 0.75 µM, 1 µM, or 5 µM) or MW1 Fab (1 µM, 3 µM, 5 µM, or 10 µM). 
Complexes containing 0:1, 1:1, 2:1, or 3:1 molar ratios of a variable concentration of Fab:HD-
39Q, where the concentration of HD-39Q was equal to the concentration of Fab in the 
equilibration buffer, were incubated for 30 minutes at room temperature in equilibration buffer 
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and then injected onto the column. Chromatography was performed at a flow rate of 50 µL/min 
using a SMART micropurification system (Pharmacia), and the absorbance of the eluent was 
monitored at 280 nm. 
 
Dynamic light scattering (DLS) 
DLS measurements were conducted on a DynaPro® NanoStarTM (Wyatt Technology, 
Goleta, CA) at 25°C. All samples were purified using a Superdex 200 10/300 column in 50 mM 
Tris (pH 8.0), 150 mM NaCl prior to DLS and SAXS measurements, and the same sample 
preparations were used for both experiments. Fractions were pooled and concentrated to at 
least 2 mg/mL and filtered through 0.2 µm membranes (Millipore). Samples were equilibrated to 
25°C prior to DLS measurements. Data were analyzed using Dynamics V7.1.2 software (Wyatt 
Technology) to calculate hydrodynamic radii (Rh). 
 
Small angle X-ray scattering (SAXS) 
Small angle X-ray scattering experiments were conducted at beamline 4-2 at SSRL 
using a Rayonix MX225-HE detector at a distance of 2500 mm, using 1.13 Å wavelength X-
rays. Protein preparations for DLS measurements were used for SAXS data collection. For each 
protein or complex, scattering intensity was measured at four protein concentrations (0.5-7 
mg/mL), collecting 10 exposures of 1 second each, covering a momentum transfer (q) range of 
0.0047-0.375 1/Å. The scattering profile for the buffer was obtained in the same manner. 
Scattering curves collected from protein samples were corrected for background scattering 
using the intensity data collected from the buffer alone using SasTool [31]. 
SAXS scattering curves were scaled, high and low q regions of scattering curves were 
merged to extrapolate to infinite dilution, and Guinier analysis was performed using PRIMUS 
[32]. Rg values were calculated from Guinier plots. Scattering curves were overlaid to check for 
concentration-dependent effects on the scattering profile. GNOM [17] was used to calculate 
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pairwise distribution functions. Porod volumes were calculated from DATPOROD [33]. 
Molecular weight was calculated by using the formula MMp = I(0)p/cp*(MMst)/(I(0)st/cst), where 
MMp and MMst are molecular masses of the protein and lysozyme standard, respectively, I(0)p 
and I(0)st are the scattering angles at zero intensity, and cp and cst are the concentrations [19]. 
The protein concentration, cp, was calculated using the equation A = ε L cp, where A is 
absorbance at 280 nm, ε is the molar extinction coefficient, and L is the path length. The 
extinction coefficient and theoretical molecular weight for a 3:1 and a 1:1 Fab:huntingtin exon 1 
protein complex are different. Because we most likely observed a mixture of 1:1, 2:1, and 3:1 
Fab:huntingtin complexes, we listed a lower limit (100% 1:1) and upper limit (100% 3:1) for 
potential complex sizes. 
For each protein or complex, at least 10 ab initio models were generated using DAMMIF 
[34]. Models were superimposed and averaged using DAMMIN [35] and DAMAVER [36] in the 
ATSAS package [33], and resulting models were filled with dummy atoms. 
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FIGURE LEGENDS 
Fig. 1. Biochemical analyses of huntingtin exon 1:3B5H10 IgG and huntingtin exon 1:MW1 IgG 
complexes. (a) Schematic of organization of human huntingtin exon 1- thioredoxin (TRX) fusion 
proteins used in this study. The bar above the domain structure represents the huntingtin exon 1 
fragment with the polyQ tract indicated by a bracket. N17, N-terminal 17 amino acid domain. 
PRR, proline rich region. (b) Western blot analysis of 3B5H10 and MW1 IgG binding to 
huntingtin exon 1 fusion proteins with variable numbers of glutamines. Both MW1 and 3B5H10 
IgGs bound to huntingtin exon 1 proteins with normal and expanded polyQ repeats, but did not 
bind the TRX-tag control (top panels). Equimolar loading of huntingtin exon 1 fusion proteins 
was verified by blotting with the N17 antibody that recognizes the first 17 residues of huntingtin 
[30] (bottom panel). Densitometry of bands in blots is shown in Fig. S1b. (c) Dot blot analysis of 
3B5H10 and MW1 IgG binding to huntingtin exon 1 fusion proteins (top panels). Equimolar 
loading of huntingtin proteins was verified by blotting with anti-TRX (bottom panel). 
Densitometry results are shown in Fig. S1c. As huntingtin concentrations decreased, binding to 
short polyQ repeats of huntingtin exon 1 protein was reduced more than binding to long polyQ 
repeats for both anti-polyQ antibodies MW1 and 3B5H10. 
 
Fig. 2. SEC-MALS profiles of huntingtin exon 1 protein and Fab:huntingtin exon 1 complexes. 
Complexes were prepared with ~3-fold molar excess of Fab for experiments with HD-39Q and 
~equal molar ratios for experiments with HD-16Q and then injected onto a Superdex 200 10/300 
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GL gel filtration column. The differential refractive index (left axis) is plotted against elution time 
from a gel filtration column and overlaid with the molar mass determined for each peak (right 
axis). 
 
Fig. 3. Non-equilibrium gel filtration chromatography analyses of Fab:HD-39Q complexes. Fabs 
of MW1 or 3B5H10 and HD-39Q were incubated at Fab:HD-39Q molar ratios of 0.25:1, 0.5:1, 
1:1, 1.5:1, 2:1, and 3:1, and passed over a gel filtration column run under non-equilibrium 
conditions. An HD-39Q concentration of 7 µM was used for all experiments. (a) 3B5H10 Fab in 
complex with HD-39Q. (b) MW1 Fab in complex with HD-39Q. 
 
Fig. 4. Equilibrium gel filtration chromatography analyses of Fab:HD-39Q complexes. MW1 or 
3B5H10 Fabs and HD-39Q were incubated at the indicated molar ratios and passed over a gel 
filtration column run in an equilibration buffer containing the indicated concentrations of 3B5H10 
or MW1 Fab. For each experiment, HD-39Q at the same concentration as the Fab in the 
equilibration buffer was incubated with Fab at Fab:HD-39Q molar ratios of 0:1, 1:1, 2:1, and 3:1 
in the equilibration buffer and injected onto a column that had been equilibrated in the 
equilibration buffer. The peak eluting first corresponds to a Fab:HD-39Q complex. The second 
peak or trough occurs at the volume where free Fab elutes. (a) 3B5H10 Fab in complex with 
HD-39Q using 0.5 µM, 0.75 µM, 1.0 µM, and 5 µM 3B5H10 Fab in the equilibration buffer. (b) 
MW1 Fab in complex with HD-39Q using 1 µM, 3 µM, 5 µM, and 10 µM MW1 Fab in the 
equilibration buffer. The stoichiometry approached 3:1 Fab:HD-39Q for both Fabs. 
 
Fig. 5. Kratky plot analyses of SAXS data for huntingtin exon 1 fusion proteins, MW1 and 
3B5H10 Fabs, and complexes of Fabs and huntingtin exon 1 proteins. Each plot shows the 
intensity of scattering plotted as Iq2 versus q, where q is scattering angle (Å-1) and I is the 
scattering intensity. (a) For MW1 and 3B5H10 Fabs, each plot exhibited one maximum, 
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indicating that these are globular proteins. (b) HD-16Q and HD-39Q showed a plateau at higher 
q values, suggesting that these proteins include disordered regions, with decreasing globular 
character as the polyQ repeat length increased. (c) Curves for 3B5H10:HD-16Q and MW1:HD-
16Q complexes were similar, each exhibiting broad single peaks. (d) Curves for 3B5H10:HD-
39Q and MW1:HD-39Q complexes were similar, each exhibiting a similar low plateau. 
 
Fig. 6. Ab initio models derived from SAXS data for huntingtin exon 1 fusion proteins, MW1 and 
3B5H10 Fabs, and Fabs:huntingtin exon 1 complexes. Calculated molecular envelopes filled 
with dummy atoms reveal the shapes of (a) 3B5H10 Fab, MW1 Fab, HD-16Q, HD-39Q, (b) 
3B5H10 Fab:HD-16Q, MW1 Fab:HD-16Q, 3B5H10 Fab:HD-39Q, MW1 Fab:HD-39Q. 
 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
23 
REFERENCES 
[1] Zuccato C, Valenza M, Cattaneo E. Molecular mechanisms and potential therapeutical 
targets in Huntington's disease. Physiological reviews. 2010;90:905-81. 
[2] Hendricks AE, Latourelle JC, Lunetta KL, Cupples LA, Wheeler V, MacDonald ME, et al. 
Estimating the probability of de novo HD cases from transmissions of expanded penetrant CAG 
alleles in the Huntington disease gene from male carriers of high normal alleles (27-35 CAG). 
American journal of medical genetics Part A. 2009;149A:1375-81. 
[3] Bennett MJ, Huey-Tubman KE, Herr AB, West AP, Jr., Ross SA, Bjorkman PJ. A linear 
lattice model for polyglutamine in CAG-expansion diseases. Proceedings of the National 
Academy of Sciences of the United States of America. 2002;99:11634-9. 
[4] Li P, Huey-Tubman KE, Gao T, Li X, West AP, Jr., Bennett MJ, et al. The structure of a 
polyQ-anti-polyQ complex reveals binding according to a linear lattice model. Nature structural 
& molecular biology. 2007;14:381-7. 
[5] Trottier Y, Lutz Y, Stevanin G, Imbert G, Devys D, Cancel G, et al. Polyglutamine expansion 
as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias. Nature. 
1995;378:4. 
[6] Klein FA, Zeder-Lutz G, Cousido-Siah A, Mitschler A, Katz A, Eberling P, et al. Linear and 
extended: a common polyglutamine conformation recognized by the three antibodies MW1, 1C2 
and 3B5H10. Human molecular genetics. 2013;22:4215-23. 
[7] Nagai Y, Inui T, Popiel HA, Fujikake N, Hasegawa K, Urade Y, et al. A toxic monomeric 
conformer of the polyglutamine protein. Nature structural & molecular biology. 2007;14:332-40. 
[8] Miller J, Arrasate M, Brooks E, Libeu CP, Legleiter J, Hatters D, et al. Identifying 
polyglutamine protein species in situ that best predict neurodegeneration. Nature chemical 
biology. 2011;7:925-34. 
[9] Peters-Libeu C, Miller J, Rutenber , Newhouse Y, Krishnan P, Cheung K, et al. Disease-
associated polyglutamine stretches in monomeric huntingtin adopt a compact structure. Journal 
of molecular biology. 2012;421:587-600. 
[10] Fodale V, Kegulian NC, Verani M, Cariulo C, Azzollini L, Petricca L, et al. Polyglutamine- 
and temperature-dependent conformational rigidity in mutant huntingtin revealed by 
immunoassays and circular dichroism spectroscopy. PloS one. 2014;9:e112262. 
[11] Cui X, Liang Q, Liang Y, Lu M, Ding Y, Lu B. TR-FRET assays of Huntingtin protein 
fragments reveal temperature and PolyQ length-dependent conformational changes. Scientific 
reports. 2014;4:5601. 
[12] Klein FA, Pastore A, Masino L, Zeder-Lutz G, Nierengarten H, Oulad-Abdelghani M, et al. 
Pathogenic and non-pathogenic polyglutamine tracts have similar structural properties: towards 
a length-dependent toxicity gradient. Journal of molecular biology. 2007;371:235-44. 
[13] Wyatt PJ. Light scattering and the absolute characterization of macromolecules. Analytica 
Chimica Acta. 1993;272:40. 
[14] Sanchez LM, Penny DM, Bjorkman PJ. Stoichiometry of the interaction between the major 
histocompatibility complex-related Fc receptor and its Fc ligand. Biochemistry. 1999;38:9471-6. 
[15] West AP, Jr., Giannetti AM, Herr AB, Bennett MJ, Nangiana JS, Pierce JR, et al. Mutational 
analysis of the transferrin receptor reveals overlapping HFE and transferrin binding sites. 
Journal of molecular biology. 2001;313:385-97. 
[16] Hummel JP, Dreyer WJ. Measurement of protein-binding phenomena by gel filtration. 
Biochim Biophys Acta. 1962;63:530-2. 
[17] Svergun DI. Determination of the regularization parameter in indirect-transform methods 
using perceptual critera. Journal of applied crystallography. 1992;25:495-503. 
[18] Vitalis A, Wang X, Pappu RV. Atomistic simulations of the effects of polyglutamine chain 
length and solvent quality on conformational equilibria and spontaneous homodimerization. 
Journal of molecular biology. 2008;384:279-97. 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
24 
[19] Mylonas E, Svergun DI. Accuracy of molecular mass determination of proteins in solution 
by small-angle X-ray scattering. Journal of applied crystallography. 2007;40:s245-s9. 
[20] Mertens HD, Svergun DI. Structural characterization of proteins and complexes using 
small-angle X-ray solution scattering. Journal of structural biology. 2010;172:128-41. 
[21] Rambo RP, Tainer JA. Accurate assessment of mass, models and resolution by small-
angle scattering. Nature. 2013;496:477-81. 
[22] Putnam CD, Hammel M, Hura GL, Tainer JA. X-ray solution scattering (SAXS) combined 
with crystallography and computation: defining accurate macromolecular structures, 
conformations and assemblies in solution. Quarterly reviews of biophysics. 2007;40:191-285. 
[23] Trewhella J, Hendrickson WA, Kleywegt GJ, Sali A, Sato M, Schwede T, et al. Report of the 
wwPDB Small-Angle Scattering Task Force: data requirements for biomolecular modeling and 
the PDB. Structure. 2013;21:875-81. 
[24] Kim MW, Chelliah Y, Kim SW, Otwinowski Z, Bezprozvanny I. Secondary structure of 
Huntingtin amino-terminal region. Structure. 2009;17:1205-12. 
[25] Caron NS, Desmond CR, Xia J, Truant R. Polyglutamine domain flexibility mediates the 
proximity between flanking sequences in huntingtin. Proceedings of the National Academy of 
Sciences of the United States of America. 2013;110:14610-5. 
[26] Butland SL, Devon RS, Huang Y, Mead CL, Meynert AM, Neal SJ, et al. CAG-encoded 
polyglutamine length polymorphism in the human genome. BMC genomics. 2007;8:126. 
[27] Schaefer MH, Wanker E, Andrade-Navarro MA. Evolution and function of 
CAG/polyglutamine repeats in protein-protein interaction networks. Nucleic acids research. 
2012;40:4273-87. 
[28] Studier FW. Protein production by auto-induction in high density shaking cultures. Protein 
expression and purification. 2005;41:207-34. 
[29] Diskin R, Scheid JF, Marcovecchio PM, West AP, Jr., Klein F, Gao H, et al. Increasing the 
potency and breadth of an HIV antibody by using structure-based rational design. Science. 
2011;334:1289-93. 
[30] Atwal RS, Desmond CR, Caron N, Maiuri T, Xia J, Sipione S, et al. Kinase inhibitors 
modulate huntingtin cell localization and toxicity. Nature chemical biology. 2011;7:453-60. 
[31] Smolsky I, Liu P, Niebuhr M, Ito K, Weiss TM, Tsuruta H. Biological small-angle X-ray 
scattering facility at the Stanford Synchrotron Radiation Laboratory. Journal of applied 
crystallography. 2007;40:453-8. 
[32] Konarev PV, Volkov VV, Sokolava AV, Koch MHJ, Svergun DI. PRIMUS- a Windows-PC 
based system for small-angle scattering data analysis. Journal of applied crystallography. 
2003;36:1277-82. 
[33] Petoukhov MV, Franke DS, Shkumatov AV, Tria G, Kikhney AG, Gajda M, et al. New 
developments in the ATSAS program package for small-angle scattering data analysis. Journal 
of applied crystallography. 2012;45:342-50. 
[34] Franke DS, Svergun DI. DAMMIF, a program for rapid ab-initio shape determination in 
small-angle scattering. Journal of applied crystallography. 2009;42:342-6. 
[35] Svergun DI. Restoring low resolution structure of biological macromolecules from solution 
scattering using simulated annealing. Biophysical journal. 1999:2897-86. 
[36] Volkov VV, Svergun DI. Uniqueness of ab-initio shape determination in small-angle 
scattering. Journal of applied crystallography. 2003;36:860-4. 
[37] Petoukhov MV, Konarev PV, Kikhney AG, Svergun DI. ATSAS 2.1 - towards automated 
and web-supported small-angle scattering data analysis. Journal of applied crystallography. 
2007;40:6. 
 
 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
25 
 
Figure 1 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
26 
 
Figure 2 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
27 
 
Figure 3 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
28 
 
Figure 4 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
29 
 
Figure 5 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
30 
 
Figure 6 
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TABLES 
Molecule or complex SEC-MALS Molecular Mass (kDa) 
 Observed Calculated 
HD-16Q 23.1 24.3 
HD-39Q 24.3 27.2 
3B5H10 Fab 44.7 48.1 
HD-16Q + 3B5H10 Fab 63.0 72.4 (1:1) 
HD-39Q + 3B5H10 Fab 110.3 75.3 (1:1) 
123.5 (2:1) 
171.5 (3:1) 
Table 1. SEC-MALS analysis of huntingtin exon 1 proteins and 3B5H10 Fab:huntingtin exon 1 
complexes. The observed and calculated molecular masses of the proteins are listed. 
 
Molecule or 
complex 
MW (kDa), 
calculated 
MW (kDa), 
observed 
R
h
 
(Å) 
R
g
 
(Å) 
D
max
 
(Å) 
Porod volume 
(105) (Å3) 
3B5H10 Fab 48,118 54,900 33 28 98 0.6 
MW1 Fab 47,330 49,300 33 26 87 0.6 
HD-16Q 24,279 40,000 40 49 168 0.8 
HD-39Q 27,226 21,700 47 52 164 0.9 
3B5H10 
Fab:HD-16Q 
72,379 62,600 37 35 128 0.8 
MW1 Fab:HD-
16Q 
71,609 71,200 41 40 141 0.9 
3B5H10 
Fab:HD-39Q 
75,344 (1:1) 
171,579 (3:1) 
137,000 - 
178,000 
59 54 194 3 
MW1 Fab:HD-
39Q 
74,556 (1:1) 
169,216 (3:1) 
125,000 - 
162,000 
52 50 173 2 
Table 2. Structural parameters of huntingtin exon 1 proteins, MW1 and 3B5H10 Fabs, and 
Fab:huntingtin exon 1 protein complexes from SAXS and DLS. MW observed, Rg, Dmax, and 
Porod volume were obtained from SAXS. Rh was obtained from DLS. The extinction coefficient 
and theoretical molecular weight for a 3:1 and a 1:1 Fab:huntingtin exon 1 protein complex are 
different; therefore two molecular weights are listed as observed for Fab:HD-39Q complexes. 
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DLS and SAXS experiments were performed on the same samples. MW, molecular weight. Rh, 
hydrodynamic radius. Rg, radius of gyration. Dmax, the maximum linear dimension of scattered 
particles. 
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HIGHLIGHTS 
• We assessed binding of MW1 and 3B5H10 anti-polyQ monoclonal antibodies and Fabs to 
normal and expanded huntingtin exon 1 polyQ repeats. 
• Western and dot blots revealed binding of MW1 and 3B5H10 IgGs to both short and 
expanded polyQ tracts in huntingtin exon 1 fusion proteins. 
• Equilibrium gel filtration studies showed that multiple MW1 or 3B5H10 Fabs bound to a 
huntingtin exon 1 fusion protein with 39 glutamines. 
• Selectivity of antibodies for specific conformations of polyQ to distinguish species of 
huntingtin exon 1 fusion protein was not observed, and no evidence for a conformational 
transition between soluble wild type and mutant huntingtin exon 1 was found. 
